Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
28 jun 2006 - 14:16
Statutaire naam
Crucell N.V.
Titel
DSM and Crucell Announce New CEO and Establishment of PER.C6® R&D Center in Boston Area
Bericht
Crucell N.V. (Euronext, NASDAQ: CRXL) and its technology partner DSM Biologics BV, a business unit of Royal DSM N.V., announced today that Dr. Marco Cacciuttolo has accepted the position of Chief Executive Officer of their joint PER.C6® R&D Center, which will be located in Cambridge, MA.
Gerelateerde downloads
Datum laatste update: 08 november 2024